Literature DB >> 16023534

Brain 3D-SSP SPECT analysis in dementia with Lewy bodies, Parkinson's disease with and without dementia, and Alzheimer's disease.

Yasunori Mito1, Kazuto Yoshida, Ichiro Yabe, Kenichi Makino, Makoto Hirotani, Kunio Tashiro, Seiji Kikuchi, Hidenao Sasaki.   

Abstract

OBJECTIVES: Cerebral blood flow was compared among patients with dementia with Lewy bodies (DLB), Parkinson's disease with dementia (PDD), Parkinson's disease without dementia (PD), and Alzheimer's disease (AD) using three-dimensional stereotactic surface projection (3D-SSP) analysis.
PURPOSE: We attempt to clarify the difference of reduction pattern on SPECT among patients having DLB, PDD, PD, AD. PATIENTS AND METHODS: Six patients with DLB, 7 patients with PDD who were matched with the DLB patients for age, unified Parkinson's disease rating scale-III (UPDRS-III) score, and degree of cognitive function disorders, 21 patients with PD who were matched with the DLB patients for age, UPDRS-III score, 12 patients with AD who were matched with the DLB patients for age and degree of cognitive function disorders, and 12 control subjects. All patients were examined by N-isopropyl-p[123I] iodoamphetamine single photon emission computed tomography (123I-IMP SPECT), and obtained images were analyzed with 3D-SSP using an image-analysis software, iSSP ver. 3.5.
RESULTS: Although DLB and PDD showed similar cerebral perfusion reduction pattern at the lateral parietal association and lateral temporal association and precuneus on SPECT by the pixel-by-pixel comparison, greater perfusion reduction was observed in DLB than in PDD. Cerebral perfusion was decreased at the occipital lobe of the DLB patients compared with the AD patients.
CONCLUSIONS: The regional pattern of blood flow reduction in the brain was found to be different among DLB, PD, and AD. Greater blood flow reduction was observed in DLB, although DLB and PDD showed similar reduction pattern. These regional differences were considered to suggest different and disease-specific combinations of underlying pathological and neurochemical processes.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16023534     DOI: 10.1016/j.clineuro.2004.12.005

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  15 in total

1.  Visual search in Dementia with Lewy Bodies and Alzheimer's disease.

Authors:  Kelly M Landy; David P Salmon; J Vincent Filoteo; William C Heindel; Douglas Galasko; Joanne M Hamilton
Journal:  Cortex       Date:  2015-09-21       Impact factor: 4.027

2.  Motion discrimination in dementia with Lewy bodies and Alzheimer disease.

Authors:  Kelly M Landy; David P Salmon; Douglas Galasko; J Vincent Filoteo; Elena K Festa; William C Heindel; Lawrence A Hansen; Joanne M Hamilton
Journal:  Neurology       Date:  2015-09-23       Impact factor: 9.910

3.  Regional CBF changes in Parkinson's disease: the importance of functional neuroimaging analyses.

Authors:  Bárbara J Amorim; Erica C S Camargo; Elba C S C Etchebehere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-09       Impact factor: 9.236

4.  Arterial spin labelling reveals an abnormal cerebral perfusion pattern in Parkinson's disease.

Authors:  Tracy R Melzer; Richard Watts; Michael R MacAskill; John F Pearson; Sina Rüeger; Toni L Pitcher; Leslie Livingston; Charlotte Graham; Ross Keenan; Ajit Shankaranarayanan; David C Alsop; John C Dalrymple-Alford; Tim J Anderson
Journal:  Brain       Date:  2011-02-09       Impact factor: 13.501

5.  White matter alteration of the cingulum in Parkinson disease with and without dementia: evaluation by diffusion tensor tract-specific analysis.

Authors:  K Kamagata; Y Motoi; O Abe; K Shimoji; M Hori; A Nakanishi; T Sano; R Kuwatsuru; S Aoki; N Hattori
Journal:  AJNR Am J Neuroradiol       Date:  2012-01-12       Impact factor: 3.825

6.  Normal model construction for statistical image analysis of torso FDG-PET images based on anatomical standardization by CT images from FDG-PET/CT devices.

Authors:  Kenshiro Takeda; Takeshi Hara; Xiangrong Zhou; Tetsuro Katafuchi; Masaya Kato; Satoshi Ito; Keiichi Ishihara; Shinichiro Kumita; Hiroshi Fujita
Journal:  Int J Comput Assist Radiol Surg       Date:  2017-02-06       Impact factor: 2.924

7.  Imaging improves diagnosis of dementia with lewy bodies.

Authors:  Masaru Tateno; Seiju Kobayashi; Toshikazu Saito
Journal:  Psychiatry Investig       Date:  2009-11-21       Impact factor: 2.505

Review 8.  Dementia with Lewy bodies.

Authors:  Tanis J Ferman; Bradley F Boeve
Journal:  Neurol Clin       Date:  2007-08       Impact factor: 3.806

9.  Serum proteomic profiling of dementia with Lewy bodies: diagnostic potential of SELDI-TOF MS analysis.

Authors:  K Wada-Isoe; K Michio; K Imamura; K Nakaso; M Kusumi; H Kowa; K Nakashima
Journal:  J Neural Transm (Vienna)       Date:  2007-08-10       Impact factor: 3.575

10.  The role of I-ioflupane SPECT dopamine transporter imaging in the diagnosis and treatment of patients with dementia with Lewy bodies.

Authors:  Angelo Antonini
Journal:  Neuropsychiatr Dis Treat       Date:  2007-06       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.